Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flow from Operating Activities:              
Net (Loss) Income $ (20,163,000) $ (16,140,000) $ 995,000 $ (13,765,000) $ (37,349,000) $ (21,726,000)  
Adjustments to reconcile to net cash used in operating activities:              
Depreciation and amortization         2,935,000 1,815,000  
Amortization of debt discount and debt issuance cost         1,949,000 325,000  
Inventory provisions 1,696,000   693,000   3,822,000 1,496,000  
Restructuring and related costs         3,791,000 0  
Gain on remeasurement of warrant liability         (2,009,000) (5,390,000)  
Non-cash lease expense         128,000 0  
Deferred tax recovery (6,650,000)   0   (6,650,000) 0  
Foreign exchange loss         1,420,000 1,137,000  
Stock-based compensation expense         2,606,000 8,137,000  
Intangible asset impairment 19,000,000   0   19,000,000 0  
Equity investment share of loss 0   14,000   64,000 39,000  
Gain on investment         (6,851,000) 0  
Loss (gain) on debt extinguishment         2,263,000 (3,375,000)  
Other non-cash expense, net         600,000 394,000  
Changes in operating assets and liabilities:              
(Increase) in accounts receivable         (369,000) (484,000)  
(Increase) in prepaid expenses         (466,000) (638,000)  
Decrease (increase) in other receivables and other non-current assets         555,000 (544,000)  
(Increase) in inventory         (5,067,000) (4,447,000)  
(Decrease) in accounts payable and other current liabilities         (4,756,000) (5,110,000)  
Increase in other non-current liabilities         415,000 176,000  
Net cash used in operating activities         (23,969,000) (28,195,000)  
Cash Flow from Investing Activities:              
Purchase of property, plant and equipment         (1,856,000) (5,948,000)  
Proceeds from partial sale of equity method investment         2,498,000 0  
Net cash provided by (used in) investing activities         642,000 (5,948,000)  
Cash Flow from Financing Activities:              
Proceeds from issuance of long-term debt         0 25,000,000  
Repayment of debt         (22,897,000) (26,363,000)  
Other borrowings         73,000 1,826,000  
Debt Issuance on Convertible debt         0 (932,000)  
Proceeds from issuance of shares         27,686,000 0  
Equity issuance costs         (1,345,000) 0  
Proceeds from exercise of warrants         0 1,410,000  
Stock option exercise         22,000 10,000  
Net cash provided by financing activities         3,539,000 951,000  
Effect of exchange rate changes on cash, cash equivalents & restricted cash         (304,000) (62,000)  
Decrease in cash, cash equivalents & restricted cash         (20,092,000) (33,254,000)  
Cash, cash equivalents & restricted cash, beginning of period   $ 37,699,000   $ 79,460,000 37,699,000 79,460,000 $ 79,460,000
Cash, cash equivalents & restricted cash, end of period $ 17,607,000 [1]   $ 46,206,000 [1]   17,607,000 [1] 46,206,000 [1] $ 37,699,000
Supplemental schedule of cash flow information:              
Cash paid for interest         220,000 375,000  
Supplemental disclosures for non-cash financing activity:              
Right-of-use assets recognized         3,871,000 0  
Conversions of debt to commons shares         3,263,000 4,209,000  
Beneficial conversion feature         $ 1,749,000 $ 0  
[1] These amounts include restricted cash of $424 and $444 as of September 30, 2022 and September 30, 2021, respectively, which are comprised primarily of cash on deposits for certain lease arrangements.